August 20th 2025
Research reveals that increased exposure to green spaces significantly reduces the risk of developing dry eye disease, highlighting urban planning's vital role in public health.
Potentially hazardous eye care products recalled nationwide
May 12th 2025BRS Analytical Service, LLC, an independent contract testing laboratory, initiated the recall because of possible concerns about product quality and safety linked to the manufacturing process. An FDA audit revealed serious manufacturing violations of Current Good Manufacturing Practice.
Brainstorming eye care research expansion with unlimited resources
From contact lens dropout to addressing diabetic retinopathy in rural communities, optometrists choose an area of eye care research that they would expand, given the appropriate resources.
Aurion Biotech unveils positive topline results from Phase 1/2 trial of AURN001 for corneal edema
December 18th 2024Aurion Biotech announced that Phase 1/2 CLARA trial of AURN001 for corneal edema demonstrated significant dose-dependent efficacy, especially in the high-dose group, with favorable safety and tolerability profiles.
2024 in the rearview: What was the biggest development in optometry this year?
A few optometrists share which innovations in optometry they were most excited about in 2024.
Does lifitegrast improve dry eye symptoms for contact lens wearers?
In 2 weeks, the study participant's dry eye symptoms improved from 76 to 43 on a 0-100 rating scale, according to Marc-Matthias Schulze, PhD, Dipl Ing.
AAOpt 2024: Eye care provider and patient satisfaction with lifitegrast
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.